Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema
about
Timely blockade of ICAM-1.LFA-1 interaction prevents disease onset in a mouse model of emphysema.Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extentNeutrophilic Inflammation in the Immune Responses of Chronic Obstructive Pulmonary Disease: Lessons from Animal Models.Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice.Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary diseaseRole of th17 cell and autoimmunity in chronic obstructive pulmonary disease.Induction of autoantibodies against lung matrix proteins and smoke-induced inflammation in mice.Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate.Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPDDesign of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)Smoking as a permissive factor of periodontal disease in psoriasis.Natural and disease-specific autoantibodies in chronic obstructive pulmonary diseaseCOPD/emphysema: The vascular story.Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia.Pathogenesis of chronic obstructive pulmonary diseaseMolecular pathogenesis of emphysemaUpdate in chronic obstructive pulmonary disease 2005.Heme oxygenase-1 prevents smoke induced B-cell infiltrates: a role for regulatory T cells?Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary diseaseState of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspectiveCurrent concepts in mechanisms of emphysema.The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.Inflammation and immune response in COPD: where do we stand?Future therapeutic treatment of COPD: struggle between oxidants and cytokinesDendritic cells in chronic obstructive pulmonary disease: new players in an old game.Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease.Induction of pulmonary antibodies against oxidized lipids in mice exposed to cigarette smoke.Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease.Eosinophil and T cell markers predict functional decline in COPD patients.Alveolar epithelial and endothelial cell apoptosis in emphysema: what we know and what we need to know.Pathogenesis of inflammation and repair in advanced COPD.Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.Role of Apoptosis in Amplifying Inflammatory Responses in Lung DiseasesImmune response in chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema.Microarray analysis of long non-coding RNAs in COPD lung tissue.Role of Apoptosis in Amplifying Inflammatory Responses in Lung Diseases.High levels of lung resident CD4+CD28null cells in COPD: implications of autoimmunity.Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.
P2860
Q30279144-3C578004-A541-493A-B4F0-88442B6CC147Q33578189-F72B6B57-0E49-49D1-9488-ABEB9CF71CFEQ33660664-634963D0-BA6B-4A13-BCFD-2BE8BB40E0B3Q33938356-88C75563-E644-4A2F-8323-4411904AD4CFQ33982284-AD2BDCE8-BF6D-4A3A-ACF5-2ACC7FA12116Q34127425-7F0079EC-F60A-46BF-AA05-9570C7A404D6Q34481700-8528503B-F95D-4F8B-A676-52C96F5DC46EQ34551954-9CA0BDBD-D8D2-4094-8EC7-8184D228BB3EQ34871266-1CD9C252-219A-4243-89C8-E291797BF9F6Q35041299-3058231E-4B4E-4472-8751-335180CAAB2AQ35126597-4FDB9D73-D6B6-4384-8CF3-6579292CE201Q35198950-3C9A6E8B-4E01-4DCC-99A4-A59C81C53EB3Q35573923-5221B569-08F0-4E6F-B57E-4A9F637B0CA5Q35941563-E251486C-8A14-47CB-9D54-E87B88900CA9Q36129048-650A5D2D-AF68-405E-BC64-F7C84BC496BDQ36407009-6A1013D0-4906-4347-AD3D-07A451A089BBQ36470462-BEE08F5F-B9D6-44CC-9F53-7DA381F2E863Q36478157-6676B39E-B5B0-4A8D-A1FA-8A947EFEB64FQ36553784-A11FC661-5ED6-4016-AC2F-FCF15E393DA5Q36571984-D34BCDE8-5688-45DE-8A9F-3FF6A2D67374Q36746478-1575D8AD-5DF3-47AE-8025-6CB3845616CAQ36945362-F82511F0-D609-4C8D-9B8E-D2FEE8FFB095Q37057836-905704EE-EF83-4ECA-A819-175287E5D4A1Q37071004-42075C62-9C41-4F8E-8E56-7B60AF8E0193Q37109162-A833AB61-DBC9-4836-AC4C-447BE9C2DF14Q37111384-D3749239-BF61-435B-8EC9-9A82C6B16FEEQ37150877-29449878-2605-4821-BCFF-C70E646DFA7FQ37413293-D6A9E943-1D87-4213-B9A9-14248F115A86Q37448511-7F204930-F2A7-4A56-9D98-29C0F7B13EF3Q37479097-104735DC-259D-4EDA-80C2-5917ECE6FCA4Q37711524-0E757384-A485-4565-BCA6-0DD1216AC121Q37836078-8AB9CC73-0EF6-4201-A509-EA63FDD3A92EQ37955890-4F2B4DF3-087F-417B-80FF-4D1068329DACQ38144104-E64D6E47-EEF7-43BD-9C36-3CA176ABD4C8Q38192501-37D15214-0797-453A-8308-D8D9ECC336A2Q38452733-545F8774-84D7-4A52-BA9E-8CD6C7F2E39EQ38468602-5E9AB3A2-CAFB-4A95-B42F-4B70B6BE7093Q39281833-5A3EA892-E67A-4BC3-A088-8EB7A27445F4Q39444602-D0EEF175-AD15-49F6-B5C9-09ECBB2D07FDQ39804008-C81F58E1-32BE-472E-8A4D-1CCAD1E12455
P2860
Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 June 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema
@en
Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema.
@nl
type
label
Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema
@en
Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema.
@nl
prefLabel
Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema
@en
Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema.
@nl
P2093
P2860
P1476
Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema
@en
P2093
Andrew K Sullivan
Andrew P Fontenot
Brian L Kotzin
Gregory P Cosgrove
John D Mitchell
Kevin K Brown
Michael T Falta
Norbert F Voelkel
Philip L Simonian
P2860
P304
P356
10.1164/RCCM.200410-1332OC
P407
P577
2005-06-03T00:00:00Z